Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00241215 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome
A Phase 4 study of Myofascial Pain Syndromes and Cervicobrachial Neuralgia, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT00241215: Completed Phase 4 study of Myofascial Pain Syndromes and Cervicobrachial Neuralgia, sponsored by University of California, Los Angeles.
NCT00241215 is a Phase 4 study of Myofascial Pain Syndromes and Cervicobrachial Neuralgia that has completed, run by University of California, Los Angeles. The registered enrollment target is 132 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00241215, a Phase 4 study of Myofascial Pain Syndromes and Cervicobrachial Neuralgia, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
Several studies have previously examined the use of botulinum toxin serotype A for myofascial pain of the neck and shoulders (cervicobrachial syndrome). These studies have suffered from: 1. inclusion of confounding conditions in the proband group, and 2. inability to identify predictors of response. This study attempts to define the characteristics of responders to botulinum serotype A for myofascial pain of the neck and shoulders (cervicobrachial syndrome).
Conditions Studied
Interventions
- DRUG Botulinum toxin serotype A
Study Locations (1)
California
- UCLA Pain Management Center - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2003-06 |
| Phase | Phase 4 |
What the finished NCT00241215 record still lists
NCT00241215 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Myofascial Pain Syndromes appearing as the primary indexed condition, and to 1 intervention - of which Botulinum toxin serotype A is the first listed.
NCT00241215 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00241215 about?
NCT00241215 is a clinical study titled "Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome". Several studies have previously examined the use of botulinum toxin serotype A for myofascial pain of the neck and shoulders (cervicobrachial syndrome). These studies have suffered from: 1. inclusion of confounding conditions in the proband group, and 2. inability to identify predictors of response...
What is the current status of trial NCT00241215?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 132 participants. The study started on 2003-06.
What conditions does trial NCT00241215 study?
This clinical trial studies the following conditions: Myofascial Pain Syndromes, Cervicobrachial Neuralgia.
What interventions are being tested in trial NCT00241215?
The interventions under investigation include: Botulinum toxin serotype A (DRUG).
Who is sponsoring clinical trial NCT00241215?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00241215 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myofascial Pain Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00241215's enrollment target sits among peer trials
132 610th of 2000 higher than 1,383 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia